Atosiban-induced Acute Pulmonary Edema: A Rare but Severe Complication of Tocolysis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Jun 12

PMID 37305518

Authors

Zuwei Yang

Wei Wu

Yi Yu

Haiyan Liu

Affiliations

Soon will be listed here.

Abstract

Background: Atosiban is commonly used to delay premature labor in pregnant women and is thought to have few side effects.

Objectives: To report a case of acute pulmonary edema (APE) following administration of atosiban and conduct a systematic review to identify common characteristics and risk factors of atosiban-associated APE.

Methods: Searches were performed in Pubmed, Embase, and Web of Science using the keyword "Atosiban" combined with the terms "Pulmonary edema" or "Dyspnea" or "Hypoxia" on 9th July 2022. Only case reports of atosiban-associated APE were included without language restrictions. Data were extracted from the reports, and median, range, and percentages were calculated as applicable. The risk of bias was assessed using the Joanna Briggs Institute critical appraisal checklist for case reports.

Results: Seven cases of atosiban-associated APE were included in the systematic review, including our case. APE occurred at a median gestational age of 32 + 6 weeks. Most patients were nulliparous (6/7, 85.7%) and were in multiple pregnancies (5/7, 71.4%). All patients were prescribed antenatal corticosteroids and tocolytics, with three (42.9%) receiving only atosiban and four (57.1%) receiving atosiban and other tocolytics. The median interval from starting atosiban administration to APE onset was about 40 h, and three patients (42.9%) showed symptoms 2-10 h after the end of atosiban treatment. Radiographic examinations (chest X-ray and/or computer tomography scan) confirmed APE in all patients and pleural effusion in four patients (57.1%). Five patients (71.4%) underwent emergency cesarean section, one patient (14.3%) with twin pregnancy had vaginal delivery with the help of suction cup and forceps, and another patient (14.3%) continued the pregnancy. All patients recovered well after administration of oxygen, diuresis, and other supportive therapy.

Conclusion: Atosiban may cause acute pulmonary edema in patients with underlying risk factors. This complication remains rare, but caution during tocolytic treatment using atosiban is recommended.

References

Seinen L, Simons S, van der Drift M, van Dillen J, Vandenbussche F, Lotgering F . [Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation]. Ned Tijdschr Geneeskd. 2013; 157(1):A5316. View

Yu Y, Yang Z, Wu L, Zhu Y, Guo F . Effectiveness and safety of atosiban versus conventional treatment in the management of preterm labor. Taiwan J Obstet Gynecol. 2020; 59(5):682-685. DOI: 10.1016/j.tjog.2020.07.010. View

Shim J, Park Y, Yoon B, Cho Y, Yang J, Lee Y . Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. BJOG. 2006; 113(11):1228-34. DOI: 10.1111/j.1471-0528.2006.01053.x. View

Sever I, Ozkul B, Erisik Tanriover D, Ozkul O, Elgormus C, Gur S . Protective effect of oxytocin through its anti-inflammatory and antioxidant role in a model of sepsis-induced acute lung injury: Demonstrated by CT and histological findings. Exp Lung Res. 2021; 47(9):426-435. DOI: 10.1080/01902148.2021.1992808. View

Ram M, Anteby M, Weiniger C, Havakuk O, Gilboa I, Shenhav M . Acute pulmonary edema due to severe preeclampsia in advanced maternal age women. Pregnancy Hypertens. 2021; 25:150-155. DOI: 10.1016/j.preghy.2021.05.019. View

Hourbracq M, Mattuizzi A, Madar H, Sentilhes L . Non-cardiogenic pulmonary edema in a woman treated with atosiban for preterm labor. Eur J Obstet Gynecol Reprod Biol. 2017; 219:132-133. DOI: 10.1016/j.ejogrb.2017.10.009. View

MOSLER K, Rosenboom H . [Newer possibilities of tocolytic treatment in obstetrics]. Z Geburtshilfe Perinatol. 1972; 176(2):85-96. View

Grignaffini A, Soncini E, RONZONI E, Lo Cane F, Anfuso S, Nardelli G . Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor. Minerva Ginecol. 2007; 59(5):481-9. View

Akerlund M, Carlsson A, Melin P, Trojnar J . The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand. 1985; 64(6):499-504. DOI: 10.3109/00016348509156728. View

10.

Shimizu K, Nanba M, Takaishi Y, Hayashi N, Yoshioka S, Yamasaki M . Acute Pulmonary Edema Induced by a Low Dose of Ritodrine Hydrochloride: A Case Report. Kobe J Med Sci. 2021; 66(5):E166-E169. PMC: 8212800. View

11.

Heus R, Mol B, Erwich J, Van Geijn H, Gyselaers W, Hanssens M . Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009; 338:b744. PMC: 2654772. DOI: 10.1136/bmj.b744. View

12.

Akerman G, Mignon A, Tsatsaris V, Jacqmin S, Cabrol D, Goffinet F . [Pulmonary edema during calcium-channel blockers therapy: role of predisposing or pharmacologic factors?]. J Gynecol Obstet Biol Reprod (Paris). 2007; 36(4):389-92. DOI: 10.1016/j.jgyn.2007.03.004. View

13.

van Winden T, Nijman T, Kleinrouweler C, Salim R, Kashanian M, Al-Omari W . Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis. BMC Pregnancy Childbirth. 2022; 22(1):567. PMC: 9284745. DOI: 10.1186/s12884-022-04854-1. View

14.

. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG. 2001; 108(2):133-42. View

15.

Patel S, Ludmir J . Drugs for the Treatment and Prevention of Preterm Labor. Clin Perinatol. 2019; 46(2):159-172. DOI: 10.1016/j.clp.2019.02.001. View

16.

Murata T, Aoyagi Y, Okimura H, Ueda A . Report from "International Workshop for Junior Fellows 2: Tocolytic treatment for prevention of preterm birth" at the 73rd Annual Congress of the Japan Society of Obstetrics and Gynecology. J Obstet Gynaecol Res. 2021; 47(11):3758-3760. DOI: 10.1111/jog.14951. View

17.

Husslein P, Cabero Roura L, Dudenhausen J, Helmer H, Frydman R, Rizzo N . Atosiban versus usual care for the management of preterm labor. J Perinat Med. 2007; 35(4):305-13. DOI: 10.1515/JPM.2007.078. View

18.

Donders G, Van Keirsbilck J, De Roo T, Schreven L, Hanssens M . Non-cardiogenic lung edema in a woman treated with atosiban for preterm labor. J Perinat Med. 2008; 36(5):455-7. DOI: 10.1515/JPM.2008.072. View

19.

Perbet S, Constantin J, Bolandard F, Vignaud M, Gallot D, Chanseaume S . [Non-invasive ventilation for pulmonary edema associated with tocolytic agents during labour for a twin pregnancy]. Can J Anaesth. 2009; 55(11):769-73. DOI: 10.1007/BF03016350. View

20.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View